Learning Objectives:

1. Defining statin intolerance

2.  Discuss alternative therapies in the new area of PCSK9 Inhibitors,  Inclisiran, Ezetimibe and Bempedoic Acid and  what to choose for your patients.

 

 

Session date: 
10/04/2024 - 7:30am to 8:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Victor Macrinici